Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1 | 1 | 1 | 3 | 1 |
| Accounts receivable | -15 | 22 | 3 | -27 | 15 |
| Accounts payable and accrued liabilities | -316 | 174 | 68 | 59 | 539 |
| Other Working Capital | 527 | 265 | 113 | -36 | 470 |
| Other Operating Activity | -846 | -1,391 | -1,164 | -1,123 | -1,666 |
| Operating Cash Flow | $-648 | $-929 | $-978 | $-1,123 | $-640 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | 0 | 2,101 | -16 |
| Other Financing Activity | 33 | 933 | 676 | 1 | -1 |
| Financing Cash Flow | $33 | $933 | $676 | $2,102 | $-17 |
| Beginning Cash Position | 918 | 869 | 1,172 | 269 | 942 |
| End Cash Position | 248 | 918 | 869 | 1,272 | 269 |
| Net Cash Flow | $-695 | $4 | $-303 | $979 | $-657 |
| Free Cash Flow | |||||
| Operating Cash Flow | -648 | -929 | -978 | -1,123 | -640 |
| Free Cash Flow | -648 | -929 | -978 | -1,123 | -640 |